Zimbabwe study finds high acceptance of cervical screening, interest in alternatives
A survey of women living with HIV at three public clinics found that most accepted visual screening, while women who declined often cited discomfort with pelvic examinations.

Most women living with HIV who took part in a survey at three public clinics in Zimbabwe accepted same-day visual cervical screening. But women who declined the examination often pointed to discomfort during pelvic exams, and the study’s summary says they showed strong interest in HPV testing options, including collecting their own samples.
The findings offer a snapshot of patient views as Zimbabwe shifts from annual visual inspection with acetic acid and cervicography, known as VIAC, toward molecular testing for human papillomavirus (HPV). The country revised its screening guidelines in 2023 to make HPV DNA testing the primary method every three to five years, with VIAC used to help determine who may need treatment.
What the survey found
Researchers surveyed 451 women aged 18 to 49 between February and June 2023 at Glenview Polyclinic in Harare, Guruve District Hospital in Mashonaland Central Province and Tsholotsho District Hospital in Matabeleland North Province. The facilities serve urban and rural communities. Overall, 414 women, or 91.8%, accepted VIAC screening on the day of the survey; 37, or 8.2%, declined.
Among women accepting screening, those returning for another test most often said they wanted reassurance about their health (45.8%). Following annual screening recommendations was the next most common reason (39.6%). For first-time screeners, encouragement from health workers was the leading reason (39.6%), followed by following annual recommendations (38.5%).
Many participants who accepted VIAC preferred to keep using it: 70.3% of returning screeners and 89.0% of first-time screeners chose visual screening as their future preference. The study authors suggested that familiarity may help explain this pattern; many participants first heard about HPV testing and self-sampling during the survey.
What the findings mean for clinics
The survey points to a practical challenge for clinics: a national move to a different test may not immediately match women’s preferences. Explaining how HPV testing works and offering acceptable ways to collect samples could matter, particularly for women who find pelvic examinations uncomfortable. The study summary does not give further details about the 37 women who declined, including how many preferred self-collection.
The results come from a convenience sample at three facilities, not a survey of all women in Zimbabwe. The study describes women attending public clinics who were living with HIV, so its findings do not establish preferences among other groups. Zimbabwe’s screening guideline change followed 2021 World Health Organization recommendations; the study does not say how widely HPV testing has since been implemented.
This report draws on information from BIOENGINEER.ORG.
Editorial checks passed Facts, figures and quotes checked against 1 source, 1 official or primary
Add Clinic Near Me as a preferred source on Google



